In healthy mice, 2-week sACVR2B-Fc administration increased the same UPR markers (GRP78, HSP47, and p-eIF2α) that also tended to be upregulated in sACVR2B-Fc administered C26 tumor-bearing mice. This evidence concerns the gene EIF2A and neoplasm.